Avantor, Inc. (NYSE:AVTR – Get Free Report) Director Gregory Lucier bought 10,000 shares of the stock in a transaction on Friday, May 8th. The shares were acquired at an average cost of $8.32 per share, for a total transaction of $83,200.00. Following the purchase, the director owned 60,000 shares in the company, valued at $499,200. The trade was a 20.00% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Avantor Price Performance
AVTR traded down $0.33 on Monday, hitting $7.99. 6,646,242 shares of the company’s stock were exchanged, compared to its average volume of 10,926,575. Avantor, Inc. has a fifty-two week low of $7.26 and a fifty-two week high of $15.93. The company has a current ratio of 1.76, a quick ratio of 1.17 and a debt-to-equity ratio of 0.68. The firm has a 50-day moving average price of $8.09 and a 200-day moving average price of $10.32. The stock has a market cap of $5.45 billion, a price-to-earnings ratio of -9.86, a P/E/G ratio of 4.85 and a beta of 0.94.
Avantor (NYSE:AVTR – Get Free Report) last announced its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.01. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.54 billion. During the same quarter in the previous year, the company posted $0.23 EPS. The firm’s quarterly revenue was up .0% on a year-over-year basis. As a group, equities analysts anticipate that Avantor, Inc. will post 0.79 earnings per share for the current year.
Hedge Funds Weigh In On Avantor
Analyst Upgrades and Downgrades
AVTR has been the topic of several analyst reports. Wells Fargo & Company reduced their price target on Avantor from $16.00 to $14.00 and set an “overweight” rating on the stock in a report on Friday, February 13th. Evercore set a $10.00 price target on Avantor in a report on Wednesday, February 11th. UBS Group reiterated a “neutral” rating and set a $10.50 price target on shares of Avantor in a report on Thursday, February 12th. Morgan Stanley set a $10.00 price target on Avantor in a report on Friday, February 13th. Finally, Stifel Nicolaus set a $10.00 price target on Avantor in a report on Thursday, February 12th. Three equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $11.39.
Check Out Our Latest Report on Avantor
Avantor Company Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Stories
- Five stocks we like better than Avantor
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
